Ratings Balaji Amines Limited

Equities

BALAMINES

INE050E01027

Delayed Bombay S.E. Other stock markets 05:22:23 2024-05-06 EDT			5-day change	1st Jan Change
2,124 ^INR	-1.36%		-3.63%	-20.40%

03-14	India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable	MT
01-31	Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

The company returns high margins, thereby supporting business profitability.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.46 times its estimated earnings per share for the ongoing year.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-20.40%	837M	D+
ECOLAB INC.	+14.70%	64.97B	A-
SIKA AG	-1.42%	47.76B	A-
GIVAUDAN SA	+14.41%	40.72B	B+
FUJIFILM HOLDINGS CORPORATION	+20.84%	26.88B	A-
EMS-CHEMIE HOLDING AG	+9.47%	19.29B	C+
CELANESE CORPORATION	+1.16%	17.53B	B+
POSCO FUTURE M CO., LTD.	-21.87%	16.03B	A-
SYMRISE AG	+1.31%	15.17B	B+
ALBEMARLE CORPORATION	-11.34%	15.06B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes